Author:
Erokhina E. K.,Melnik E. A.,Lebedeva D. D.,Shamtieva K. V.,Peters T. V.,Pavlikova E. P.,Gepard V. V.,Vlodavets D. V.
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Pešović, J., Perić, S., Brkušanin, M., et al., “Molecular genetic and clinical characterization of myotonic dystrophy type 1 patients carrying variant repeats within DMPK expansions,” Neurogenetics, 18, No. 4, 207–218 (2017).
2. Lagrue, E., Dogan, C., De Antonio, M., et al., “A large multicenter study of pediatric myotonic dystrophy type 1 for evidence-based management [published correction appears in Neurology 94, No. 9, 414 (2020)],” Neurology, 92, No. 8, 852–865 (2019).
3. Wenninger, S., Montagnese, F., and Schoser, B., “Core clinical phenotypes in myotonic dystrophies,” Front. Neurol., 9, 303 (2018).
4. Ivanova, E. O., Moskalenko, A. N., and Fedotova, A. T., et al., “Myotonic dystrophy: genetics and polymorphism of clinical manifestations,” Ann. Klin. Eksperim. Nevrol., 13, No. 1, 15–25 (2019).
5. Thornton, C. A., “Myotonic dystrophy,” Neurol. Clin., 32, No. 3, 705–710 (2014).